Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank A Post

Showing results (141-150 of 171) with videos related to

Pageof 18
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY TrialFrank A Post, Alexander J Szubert, Andrew J Prendergast, et al.
HIV Medicine|January 29, 2026
Screening for Trypanosoma cruzi infection (Chagas disease) in the Latin American population living with HIV in LondonNatalie Elkheir, Shivani Singh, Birgit Barbini, et al.
The Lancet. HIV|March 6, 2017
Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority studyEdwin DeJesus, Moti Ramgopal, Gordon Crofoot, et al.
JAMA|July 24, 2012
Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trialNicholas I Paton, Ruth L Goodall, David T Dunn, et al.
European Journal of Pain (London, England)|March 12, 2021
Feasibility randomized-controlled trial of online acceptance and commitment therapy for painful peripheral neuropathy in people living with HIV: The OPEN studyWhitney Scott, Beth J Guildford, James Badenoch, et al.
The Lancet. Infectious Diseases|January 19, 2019
Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort studyHilary S Whitworth, Amarjit Badhan, Aime A Boakye, et al.
Plos One|December 31, 2015
Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin AmericaAnne Marie W Efsen, Anna Schultze, Frank A Post, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 3, 2015
Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 StudyAnton Pozniak, Jose R Arribas, Joseph Gathe, et al.
The Lancet. HIV|March 5, 2016
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort studyDaria N Podlekareva, Anne Marie W Efsen, Anna Schultze, et al.
AIDS (London, England)|November 10, 2009
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and ArgentinaDaria N Podlekareva, Amanda Mocroft, Frank A Post, et al.
Pageof 18

Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY TrialFrank A Post, Alexander J Szubert, Andrew J Prendergast, et al.
HIV Medicine|January 29, 2026
Screening for Trypanosoma cruzi infection (Chagas disease) in the Latin American population living with HIV in LondonNatalie Elkheir, Shivani Singh, Birgit Barbini, et al.
The Lancet. HIV|March 6, 2017
Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority studyEdwin DeJesus, Moti Ramgopal, Gordon Crofoot, et al.
JAMA|July 24, 2012
Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trialNicholas I Paton, Ruth L Goodall, David T Dunn, et al.
European Journal of Pain (London, England)|March 12, 2021
Feasibility randomized-controlled trial of online acceptance and commitment therapy for painful peripheral neuropathy in people living with HIV: The OPEN studyWhitney Scott, Beth J Guildford, James Badenoch, et al.
The Lancet. Infectious Diseases|January 19, 2019
Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort studyHilary S Whitworth, Amarjit Badhan, Aime A Boakye, et al.
Plos One|December 31, 2015
Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin AmericaAnne Marie W Efsen, Anna Schultze, Frank A Post, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 3, 2015
Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 StudyAnton Pozniak, Jose R Arribas, Joseph Gathe, et al.
The Lancet. HIV|March 5, 2016
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort studyDaria N Podlekareva, Anne Marie W Efsen, Anna Schultze, et al.
AIDS (London, England)|November 10, 2009
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and ArgentinaDaria N Podlekareva, Amanda Mocroft, Frank A Post, et al.
Pageof 18